GLG LLC’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$2.53M Hold
25,662
0.18% 145
2017
Q3
$2.4M Sell
25,662
-2,386
-9% -$253K 0.16% 169
2017
Q2
$3.12M Buy
28,048
+19,064
+212% +$2.02M 0.19% 146
2017
Q1
$882K Sell
8,984
-20
-0.2% -$1.91K 0.05% 358
2016
Q4
$827K Buy
9,004
+573
+7% +$49.4K 0.06% 310
2016
Q3
$714K Sell
8,431
-706
-8% -$59.3K 0.05% 330
2016
Q2
$744K Sell
9,137
-1,375
-13% -$105K 0.06% 313
2016
Q1
$751K Sell
10,512
-138
-1% -$9.26K 0.05% 359
2015
Q4
$758K Sell
10,650
-5,190
-33% -$349K 0.05% 365
2015
Q3
$974K Sell
15,840
-52
-0.3% -$3.63K 0.02% 413
2015
Q2
$1.15M Sell
15,892
-246
-2% -$18.2K 0.02% 456
2015
Q1
$1.24M Buy
16,138
+1,472
+10% +$105K 0.04% 400
2014
Q4
$984K Hold
14,666
0.03% 455
2014
Q3
$890K Hold
14,666
0.02% 517
2014
Q2
$861K Hold
14,666
0.03% 536
2014
Q1
$849K Buy
+14,666
New +$786K 0.03% 508

Other funds holding DGX

GLG LLC's DGX Position: Q4 2017 in Review

GLG LLC held its Quest Diagnostics (DGX) position steady in Q4 2017 at 25,662 shares worth $2.53M. The position accounts for 0.18% of the portfolio, ranked #145.

GLG LLC first reported a position in DGX in Q1 2014 and has held it in 16 quarters since. The position peaked at $3.12M in Q2 2017. 631 funds tracked by Wall St. Rank hold DGX as of Q4 2017.

  • GLG LLC held 25,662 shares of Quest Diagnostics worth $2.53M as of Q4 2017.
  • GLG LLC left its Quest Diagnostics share count unchanged in Q4 2017.
  • Quest Diagnostics made up 0.18% of GLG LLC's portfolio in Q4 2017, its #145 holding.
  • GLG LLC first reported a position in Quest Diagnostics in Q1 2014 and has held it in 16 quarters since.
  • GLG LLC's Quest Diagnostics position peaked at $3.12M in Q2 2017.
  • 631 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2017.

Based on GLG LLC's 13F filing for Q4 2017, filed 14 Feb 2018.